P3 Health Partners Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.5B+0.2% YoYTTM through 30 Jun 2026
Net Income -$98.4MTTM through 30 Jun 2026
Free Cash Flow -$130.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | -4.1% |
| EBITDA Margin | -4.3% |
| Operating Margin | -18.5% |
| Net Margin | -6.6% |
Returns
63.4%ROE
-15.0%ROA
Balance Sheet Health
Debt / Equity-2.17x
Current Ratio0.20x
Net Debt$311.7M
Cash & Equivalents$21.3M
Quality Metrics
Altman Z-Score1.57
Piotroski F-Score4 / 9
FCF Margin-8.7%
Rule of 40-7.3
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $1.5B
Diluted EPS-$33.01TTMFY2025: $-45.26
Dividend
No dividend
Capital Allocation
Capex Intensity0.0%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.